SGCB and diabetic kidney disease: The above ZSF1 rat DKD model was also used to study the effect of pharmacological soluble guanylate cyclase (sGC) modulation on multiple cell types by scRNA-seq, and it validated that sGC was a promising DKD drug target [49].